Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
MTX-211 is a dual inhibitor of PI3Kα and EGFR (IC50s = <100 nM for both).1 It reduces viability of 5637, EJ, and UM-UC-3 bladder cancer cells (IC50s = 1.075, 1.514, and 2.189 µM, respectively), an effect that can be partially inhibited by glutathione (GSH).2 MTX-211 also induces apoptosis, increases the levels of the Nrf2 binding protein Keap1, and reduces the levels of Nrf2 and GSH in 5637 and EJ cells. It reduces tumor growth in a 5637 mouse xenograft model when administered at a dose of 10 mg/kg.
WARNING This product is not for human or veterinary use.
1. Samll molecule inhibitors of EGFR and PI3K. (2016).
2. MTX-